ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
Hormone-receptor positive breast cancer is the most common molecular subtype and represents 60–75 % of all breast cancers (BC). The presence of specific molecular targets such as the estrogen/progesterone receptor determines the use of hormone therapy for patients with this subtype. Tamoxifen, a sel...
| Автори: | , , , , , , |
|---|---|
| Формат: | Стаття |
| Мова: | Russian |
| Опубліковано: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2020-09-01
|
| Серія: | Сибирский онкологический журнал |
| Предмети: | |
| Онлайн доступ: | https://www.siboncoj.ru/jour/article/view/1540 |